(Q36069250)

12 August 2017

1 reference

title

An integrated approach for inference and mechanistic modeling for advancing drug development (English)

1 reference

12 August 2017

Sergej V Aksenov

1

1 reference

12 August 2017

Bruce Church

2

1 reference

12 August 2017

Anjali Dhiman

3

1 reference

12 August 2017

Anna Georgieva

4

1 reference

12 August 2017

Ramesh Sarangapani

5

1 reference

12 August 2017

Gabriel Helmlinger

6

1 reference

12 August 2017

Iya G Khalil

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

12 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

12 August 2017

579

1 reference

12 August 2017

8

1 reference

12 August 2017

1878-1883

1 reference

Issues and progress with protein kinase inhibitors for cancer treatment

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Clinical biomarkers in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Computational analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Inferring genetic networks and identifying compound mode of action via expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Genetic network inference: from co-expression clustering to reverse engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Using Bayesian networks to analyze expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Reverse engineering of genetic networks with Bayesian networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Evaluating functional network inference using simulations of complex biological systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Advances to Bayesian network inference for generating causal networks from observational biological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Inferring cellular networks using probabilistic graphical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Use of logic relationships to decipher protein network organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

An integrated model of epidermal growth factor receptor trafficking and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

A model for restriction point control of the mammalian cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Periodic signaling controlled by an oscillatory circuit that includes protein kinases ERK2 and PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Modeling the early signaling events mediated by FcepsilonRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

In silico simulation of inhibitor drug effects on nuclear factor-kappaB pathway dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Data-driven computer simulation of human cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Small- and large-scale biosimulation applied to drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Parameter estimation in biochemical pathways: a comparison of global optimization methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Statistical mechanical approaches to models with many poorly known parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

Proteomics: the first decade and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.012

10.1016/J.FEBSLET.2005.02.012

21 January 2018

Identifiers

DOI

1 reference

release_uttkmf2pwbf67hyeogh3kylqrm

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uttkmf2pwbf67hyeogh3kylqrm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference